Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis-Reference-Cited by-同舟云学术

Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis

Published:2018-09-11 Issue:5 Volume:122 Page:879-888
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Erman Aysegul¹²^ORCID,Masucci Lisa¹³,Krahn Murray D.¹²³,Elterman Dean S.⁴⁵

Affiliation:

1. Toronto Health Economics and Technology Assessment Collaborative (THETA); University of Toronto; Toronto ON Canada

2. Leslie Dan Faculty of Pharmacy; University of Toronto; Toronto ON Canada

3. Institute of Health Policy, Management, and Evaluation; University of Toronto; Toronto ON Canada

4. Division of Urology; University of Toronto; Toronto ON Canada

5. Krembil Research Institute; Toronto Western Hospital; University Health Network; Toronto ON Canada

Funder

Boston Scientific Corporation

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14520/fullpdf

Reference33 articles.

1. Benign prostatic hyperplasia (BPH) management in the primary care setting;Kapoor;Can J Urol,2012

2. Urologic diseases in America project: benign prostatic hyperplasia;Wei;J Urol,2008

3. American Urological Association American Urological Association Guideline: Management of Benign Prostatic Hyperplasia (BPH), revised 2010 https://www.auanet.org/common/pdf/education/clinical-guidance/Benign-Prostatic-Hyperplasia.pdf

4. Photoselective vaporization for the treatment of benign prostatic hyperplasia;Bowen;Ont Health Technol Assess Ser,2013

5. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: a systematic review and meta-analysis;Teng;BJU Int,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenging the Gold Standard Transurethral Resection of the Prostate with Holmium Laser Enucleation in the Treatment of Benign Prostatic Hyperplasia: Paradigm Shift in Northern Cyprus;Diseases of Prostate - Management Strategies and Emerging Technologies [Working Title];2024-09-10

2. Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions;Expert Opinion on Pharmacotherapy;2024-05-02

3. Evaluation of Private Payer and Patient Out-of-Pocket Costs Associated With the Surgical Management of Benign Prostatic Hyperplasia;Urology;2023-12

4. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore;Journal of Medical Economics;2023-10-14

5. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial;The Lancet Regional Health - Europe;2023-08